Use of aminoglycosides in preterm neonates: A simple task?

Journal of Pediatrics

Volumn 154, Issue 6, 2009, Pages 935-

  van den Anker, John ^a  

^a Children's National Medical Center   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN; TOBRAMYCIN;

DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG MONITORING; GESTATIONAL AGE; HUMAN; LETTER; MEDICAL LITERATURE; NURSERY; PHARMACY; PREMATURITY; PRIORITY JOURNAL;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE;

EID: 65549140292     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2009.01.021     Document Type: Letter

References (4)

1. Thingvoll E.S., Gullet R., Caserta M., and DiCenzo R. Observational trial of a 48-hour gentamicin dosing regimen derived from Monte Carlo simulations in infants born at less than 28 weeks' gestation. J Pediatr 153 (2008) 530-534
2. De Hoog M., Schoemaker R.C., Mouton J.W., and van den Anker J.N. Tobramycin population pharmacokinetics in neonates. Clin Pharmacol Ther 62 (1997) 392-399
3. De Hoog M., Mouton J.W., Schoemaker R.C., Verduin C.M., and van den Anker J.N. Extended interval dosing of tobramycin in neonates: implications for therapeutic drug monitoring. Clin Pharmacol Ther 71 (2002) 349-358
4. De Hoog M., Mouton J.W., and van den Anker J.N. New dosing strategies for antibacterial agents in the neonate. Semin Fetal Neonatal Med 10 (2005) 185-194